Skip to main content
Premium Trial:

Request an Annual Quote

Upgrade Time?

Early 23andMe customers haven't been getting updated reports, while more recent customers have been getting regular updates, Wired reports. That, it adds, is largely due to changes the company has made in what genotyping chips it uses.

The newer chips 23andMe has been using from Illumina include both more and different variants than the older ones, it notes, which has allowed the company to be more efficient and analyze more complex variants. The newer chips have also enabled it to return more health data. But that, Wired notes, means that users who were tested using older arrays can't get the same data back.

23andMe said that saliva samples from older customers would be re-run on the newer arrays, but Wired reports that the company recently said that those customers would have to send in new samples and pay a fee, though discounted, to be re-analyzed.

Wired notes that this serves as a reminder that "such tests are consumer products and, like phones and laptops, they're constantly evolving."

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.